Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel Disease.
Journal: Frontiers in immunology
Published: February 21, 2022
The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy.
Journal: Inflammatory bowel diseases
Published: January 04, 2022
The T-cell clonal response to SARS-CoV-2 vaccination in inflammatory bowel disease patients is augmented by anti-TNF therapy and often deficient in antibody-responders.
Journal: medRxiv : the preprint server for health sciences
Published: December 15, 2021
Characteristics of foot fractures in HIV-infected patients previously treated with tenofovir versus non-tenofovir-containing highly active antiretroviral therapy.
Journal: HIV/AIDS (Auckland, N.Z.)
Published: November 19, 2011
Showing 1-5 of 5
Last Updated: 09/26/2026